Atrial Fibrillation Therapy Selection via Hemodynamic Feedback

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating atrial fibrillation (AF) lack individualized approaches to effectively manage hemodynamic responses, leading to unreliable evaluation of therapy efficacy and potential worsening of congestive heart failure (CHF) due to the challenges in detecting atrial activity signals amidst noise and ventricular contraction irregularities.

Innovation Solution

A system comprising an AF detection circuit, programmable therapy circuits, and a hemodynamic sensor circuit that automatically selects a therapy by sensing hemodynamic status outputs during the delivery of candidate therapies, allowing for personalized AF treatment based on heart sound analysis and cardiac timing intervals to improve hemodynamic stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If traditional AF therapy methods are used, then treatment can be provided, but individualized therapy selection based on hemodynamic responses cannot be achieved

Engineering Contradiction:
Improveindividualized therapy selectionVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system continuously monitors hemodynamic parameters (cardiac output, heart rate, blood pressure) during therapy delivery and uses this feedback to automatically adjust and select the most effective therapy. The therapy selection circuit compares real-time hemodynamic responses to predetermined criteria and switches between candidate therapies accordingly, enabling individualized treatment without requiring complex manual programming.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The implantable device autonomously performs therapy selection and adjustment without requiring external programmer intervention. The therapy selection circuit automatically evaluates hemodynamic responses, compares them against stored criteria, and selects appropriate therapies from candidate therapies stored in memory, making the system self-sufficient in adapting treatment to the patient's real-time physiological state.

Inventive Principle:
Principle #25Self-service

2Measurement precision

If hemodynamic monitoring is implemented to evaluate therapy efficacy, then accurate therapy selection is improved, but device complexity increases

Engineering Contradiction:
Improvetherapy efficacy evaluation accuracyVSAvoidmonitoring system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The implantable device integrates multiple functions into a single system: AF detection, hemodynamic parameter monitoring, candidate therapy storage, and automatic therapy selection. The therapy selection circuit utilizes existing hemodynamic sensors and processing capabilities already present in the device, eliminating the need for separate dedicated monitoring equipment and reducing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If multiple candidate therapies are sequentially delivered to determine hemodynamic response, then individualized therapy selection is improved, but treatment time increases

Engineering Contradiction:
Improvepersonalized treatmentVSAvoidtherapy determination time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The system delivers candidate therapies in a sequential manner but limits the evaluation to a predetermined time period for each therapy. If hemodynamic improvement meets predetermined criteria within this time window, the therapy is selected immediately without waiting to test all candidate therapies, thus reducing the overall time required for therapy determination while still achieving personalized treatment selection.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS9770584B2System and methods for treating atrial fibrillation using hemodynamic responses
Publication Date: 2017.09.26 CARDIAC PACEMAKERS INC
  • US9770584B2 patent drawing
  • US9770584B2 patent drawing
  • US9770584B2 patent drawing

AI summary

Systems and methods for treating atrial tachyarrhythmias such as atrial fibrillation (AF) are disclosed. By monitoring a patient's hemodynamic sensor response to a candidate AF therapy, the present systems and methods can be used to determine an individualized AF therapy leading to a desirable hemodynamic outcome. A medical system can include one or more programmable therapy circuits and a hemodynamic sensor circuit. The system includes a therapy selection circuit that automatically programs and sequentially delivers at least a first candidate therapy and a different second candidate therapy. By comparing the values of a hemodynamic parameter in response to or during the first candidate therapy to that in response to or during the second candidate therapy, a desired AF therapy can be determined as the candidate therapy that leads to faster or more significant hemodynamic recovery.